Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 33
Phase 42

Trial Status

Completed1
Recruiting1
Terminated1
Other4

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT05749666Phase 3Unknown
Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis
Takayasu Arteritis
PrincipalinvestigatorStart date: 2023-01-20
NCT03096275Phase 3Completed
Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis
Takayasu Arteritis
PrincipalinvestigatorStart date: 2017-03-16
NCT02444728Phase 3Terminated
Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
Thrombocytopenia
Principalinvestigator
NCT02764515Phase 4Unknown
Kunxian for the Treatment of Rheumatoid Arthritis
Rheumatoid Arthritis
Principalinvestigator
NCT05805891Not ApplicableUnknown
Bortezomib for the Treatment of Refractory Rheumatoid Arthritis
Rheumatoid Arthritis
Principalinvestigator
NCT07008196Phase 4Not Yet Recruiting
Telitacicept for the Treatment of Refractory RA
Rheumatoid Arthritis (RA)
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peking Union Medical College Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiaofeng Zeng, MD

Peking Union Medical College Hospital

Moderately Similar
7 trials

Shared therapeutic areas:

Arthritis, RheumatoidTakayasu ArteritisThrombocytopenia

Worked with same sponsors:

CHENLIJI Pharmaceutical Company,Guangzhou Pharmaceutical GroupCHINESE RHEUMATISM DATA CENTER+2 more
Collaborated on 2 trials
Similarity Score38%

Xiaofeng Zeng, MD

Chinese SLE Treatment And Research Group

Related
1 trials

Shared therapeutic areas:

Thrombocytopenia

Worked with same sponsors:

Chinese SLE Treatment And Research GroupPeking Union Medical College Hospital
Collaborated on 1 trial
Similarity Score14%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Arthritis, RheumatoidRheumatoid Arthritis (RA
Similarity Score12%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Arthritis, Rheumatoid
Similarity Score6%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Arthritis, Rheumatoid
Similarity Score6%

Hillary Overholser

Zimmer Biomet

Related
19 trials

Shared therapeutic areas:

Arthritis, Rheumatoid
Similarity Score6%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Arthritis, Rheumatoid
Similarity Score6%

Alan Kivitz, MD

Altoona Center for Clinical Research

Related
7 trials

Shared therapeutic areas:

Arthritis, Rheumatoid
Similarity Score6%

Thomas Raife, MD

University of Iowa

Related
3 trials

Shared therapeutic areas:

Thrombocytopenia
Similarity Score6%

Neal S Young, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Thrombocytopenia
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT05749666Phase 3PrincipalInvestigator

Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis

Takayasu Arteritis
Unknown
NCT03096275Phase 3PrincipalInvestigator

Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis

Takayasu Arteritis
Completed
NCT02444728Phase 3PrincipalInvestigator

Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE

Thrombocytopenia
Terminated
NCT02764515Phase 4PrincipalInvestigator

Kunxian for the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis
Unknown
NCT05805891Not ApplicablePrincipalInvestigator

Bortezomib for the Treatment of Refractory Rheumatoid Arthritis

Rheumatoid Arthritis
Unknown
NCT06167174PrincipalInvestigator

Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis

Lupus Nephritis
Recruiting
NCT07008196Phase 4PrincipalInvestigator

Telitacicept for the Treatment of Refractory RA

Rheumatoid Arthritis (RA)
Not Yet Recruiting

All 7 trials loaded